Scientific Reports 5: Article number: 953010.1038/srep09530; published online: April012015; updated: August052015.
This Article contains a typographical error in the Results section under subheading ‘Identification of F12016 as a novel selective PPARγ agonist distinct from rosiglitazone’.
“The chemical name of F12016 is 2-[2-(1, 2-dimethyl-1H-indol-3-yl)-2-oxo-acetylamino]-benzamide, which has not been reported to show any activity.”
should read:
“The chemical name of F12016 is N-(2-acetylpheyl)-2-(1,2-dimethyl-1H-indol-3-yl)-2-oxoacetamide, which has not been reported to show any activity.”